Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Integrated BioPharma (OTC: INBP) Appoints Michael Richtmyer as Head of Operations

This strategic decision, announced on August 20, 2026, aims to bolster operational capabilities within MDC. Richtmyer's role will involve overseeing operational strategies that focus on improvingManufacturingefficiency, ensuring supply chain reliability, and enhancing productivity. His appointment signals a clear commitment by Integrated BioPharma to strengthen …

Vinay Lochav | 21 August 2026

Capricor Therapeutics (NASDAQ: CAPR) Reports Q2 Loss of $-0.70, Shares Decline 0.6%

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on innovative therapies for rare diseases, reported a second-quarter loss of $-0.70 per share, below the $-0.60 consensus estimate. This disappointing performance reflects ongoing challenges in advancing its lead product, Deramiocel, a treatment for Duchenne muscular …

Vinay Lochav | 21 August 2026

Amylyx Pharmaceuticals (NASDAQ: AMLX) Secures $471.7M to Fund Avexitide Launch

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has entered into an underwriting agreement, facilitating the sale of 14,090,000 shares of its common stock at a public price of $35.50 per share. This transaction, if finalized, is expected toYieldapproximately $471.7 million for the company. If the underwriters …

Vinay Lochav | 21 August 2026

Bicycle Therapeutics PLC (NASDAQ: BCYC) Board Faces Transition After Director Resignation

Bicycle Therapeutics (NASDAQ: BCYC) PLC has announced the immediate resignation of Charles Swanton from its Board of Directors. This change takes effect as of August 18, 2026. Swanton served as a Class II director and was also involved with several Board committees and the …

Vinay Lochav | 21 August 2026

Abbott Laboratories (NYSE: ABT) to Address 12,700 Infant Claims With $670 Million

Abbott Laboratories (NYSE: ABT) has reached significant agreements to settle ongoing litigation concerning its specialty formulas designed for preterm infants, totaling approximately $670 million. This settlement addresses claims related to the high-profile Gill case, where a jury awarded $495 million in damages, and involves …

Vinay Lochav | 21 August 2026

Aveanna Healthcare (NASDAQ:AVAH) Stock Drops 9% in Premarket. Here's What the Selling Is About

• AVAH shares traded around $11.85 in premarket, down about 8.64 percent from a prior close of $12.97.

Nitish Kishor | 21 August 2026

This Penny Stock Just Hit a Major Trial Milestone. So Why Is It Falling in Premarket Trading?

• BDRX shares traded around $1.22 in premarket, down about 3.17 percent from a prior close of $1.26.

Nitish Kishor | 21 August 2026

This Penny Stock Just Launched the World's Largest Zcash Mining Fleet. It's Up 11% in Premarket

• The company launched aZCashMiningfleet representing approximately 18 percent of the total network hashrate.

Nitish Kishor | 21 August 2026

Haemonetics (NYSE:HAE) Holds Steady in Premarket Near 52-Week Highs After 16% Weekly Rally

• HAE shares were little changed in premarket trading, holding near $107.72, close to their 52-week high of $109.56.

Nitish Kishor | 21 August 2026
Support

Hi! How can we help you today?

Loading…